Growth Metrics

Resmed (RMD) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $78.0 million.

  • Resmed's Non-Current Deferred Tax Liability rose 128.56% to $78.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $78.0 million, marking a year-over-year increase of 128.56%. This contributed to the annual value of $77.7 million for FY2025, which is 208.85% down from last year.
  • According to the latest figures from Q4 2025, Resmed's Non-Current Deferred Tax Liability is $78.0 million, which was up 128.56% from $77.6 million recorded in Q3 2025.
  • Resmed's Non-Current Deferred Tax Liability's 5-year high stood at $113.0 million during Q1 2023, with a 5-year trough of $9.7 million in Q2 2022.
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $77.8 million (2025), whereas its average is $60.4 million.
  • As far as peak fluctuations go, Resmed's Non-Current Deferred Tax Liability plummeted by 5096.89% in 2021, and later skyrocketed by 95513.02% in 2023.
  • Quarter analysis of 5 years shows Resmed's Non-Current Deferred Tax Liability stood at $12.9 million in 2021, then skyrocketed by 735.39% to $107.5 million in 2022, then dropped by 16.98% to $89.3 million in 2023, then decreased by 13.75% to $77.0 million in 2024, then grew by 1.29% to $78.0 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $78.0 million for Q4 2025, versus $77.6 million for Q3 2025 and $77.7 million for Q2 2025.